Summary: Reason Magazine explores psychedelic research in the 21st century, covering MAPS’ recent Psychedelic Science 2017 conference and decades of MAPS’ ongoing MDMA research. “I saw early on the value of scientific research and fully believed in the idea of working through the FDA’s clinical research procedures to obtain approval for prescription use,” explains MAPS Founder Rick Doblin, Ph.D. “I’d seen the backlash against the ’60s and realized that incremental change, evolutionary rather than revolutionary, was going to be required. I just didn’t realize I’d still be working towards the medicalization of psychedelics 45 years later!”